#1 Clinical Trials Search in Europe

Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • Title: Long-term treatment study of oral decitabine and cedazuridine combination for patients with AML, MDS, CMML, or solid tumors who previously received ASTX727

    Recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Bulgaria Germany Hungary Poland Romania +2

  • Study on Long-Term Safety of Luspatercept for Patients with Myelodysplastic Syndrome, Beta-Thalassemia, or Myelofibrosis Who Previously Participated in Luspatercept Trials

    Recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria France Germany Greece Italy The Netherlands +2

  • Study on Azacitidine for Patients with Myelodysplastic Syndrome After Stem Cell Transplantation

    Recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Denmark Finland Norway Sweden

  • Study Comparing Thymoglobulin and Grafalon for Preventing Graft Versus Host Disease in Elderly Patients with Acute Myeloid Leukemia or Myelodysplastic Syndrome

    Recruiting

    3 1 1 1
    Investigated Drugs:
    Belgium France

  • Study of EP0042 alone and in combination with venetoclax and azacitidine in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML)

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study on the Effectiveness and Safety of Imetelstat for Patients with High-Risk Myelodysplastic Syndromes or Acute Myeloid Leukemia After HMA Therapy Failure

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany

  • Study of Natural Killer Cells and Aldesleukin for Patients with Acute Myeloid Leukemia

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    The Netherlands

  • Study of luspatercept in patients with low-risk myelodysplastic syndrome (MDS) who do not require blood transfusions and have not received erythropoiesis treatment

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany

  • Study of Emavusertib for Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

    Not recruiting

    1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France Germany Spain

  • Study on Continued Treatment with Sabatolimab for Adults with High-Risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Acute Myeloid Leukemia Unfit for Chemotherapy

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Czechia France Germany Greece Italy Spain